Form 8-K Horizon Therapeutics For: Apr 28 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Detailed results to be presented at upcoming medical congress Horizon Therapeutics plc (Nasdaq: HZNP) today announced that its Phase 2, randomized, double-blinded, placebo-controlled trial of dazodalibep
NMOSD is a devastating autoimmune disease of severe and recurrent central nervous system attacks which can result in blindness, paralysis and death UPLIZNA is indicated as monotherapy for
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of the RAREis Global Advocate Grant, a new program designed to support the rare disease community by providing financial assistance